KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Current Deferred Tax Assets: 2009-2015

Historic Current Deferred Tax Assets for Teva Pharmaceutical Industries (TEVA) over the last 7 years, with Dec 2015 value amounting to $735.0 million.

  • Teva Pharmaceutical Industries' Current Deferred Tax Assets fell 25.98% to $735.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was $735.0 million, marking a year-over-year decrease of 25.98%. This contributed to the annual value of $735.0 million for FY2015, which is 25.98% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Current Deferred Tax Assets of $735.0 million as of FY2015, which was down 25.98% from $993.0 million recorded in FY2014.
  • Teva Pharmaceutical Industries' Current Deferred Tax Assets' 5-year high stood at $1.1 billion during FY2012, with a 5-year trough of $735.0 million in FY2015.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Current Deferred Tax Assets value was $993.0 million (recorded in 2014), while the average stood at $937.3 million.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Current Deferred Tax Assets crashed by 33.47% in 2011 and then rose by 18.22% in 2012.
  • Over the past 5 years, Teva Pharmaceutical Industries' Current Deferred Tax Assets (Yearly) stood at $966.0 million in 2011, then increased by 18.22% to $1.1 billion in 2012, then fell by 5.08% to $1.1 billion in 2013, then decreased by 8.39% to $993.0 million in 2014, then decreased by 25.98% to $735.0 million in 2015.